Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B
Hereditas · 2024
DOI: 10.1186/s41065-024-00357-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hereditas, 2024. Verfasst von Valeria Villarreal-García und 14 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo Leó…. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Cell Proliferation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences (NIGMS) Support for Research Excellence (SuRE) Program (R16), Fondo Sectorial de Investigación para la Educación CB2017-2018, Programa Presupuestario F003 of the Consejo Nacional de Humanidades, Ciencia y Tecnología (CONA….
Abstract (Originalsprache)
Background
Breast cancer is the most prevalent cancer among women worldwide. Most breast cancer-related deaths result from metastasis and drug resistance. Novel therapies are imperative for targeting metastatic and drug-resistant breast cancer cells. Accumulating evidence suggests that dysregulated microRNAs (miRNAs) promote breast cancer progression, metastasis, and drug resistance. Compared with healthy breast tissue, miR-660-5p is notably overexpressed in breast cancer tumor tissues. However, the downstream effectors of miR-660-5p in breast cancer cells have not been fully elucidated. Our aim was to investigate the role of miR-660-5p in breast cancer cell proliferation, migration, invasion, and angiogenesis and to identify its potential targets.
Results
Our findings revealed significant upregulation of miR-660-5p in MDA-MB-231 and MCF-7 cells compared with MCF-10 A cells. Furthermore, inhibiting miR-660-5p led to notable decreases in the proliferation, migration, and invasion of breast cancer cells, as well as angiogenesis, in HUVEC cells. Through bioinformatics analysis, we identified 15 potential targets of miR-660-5p. We validated TMEM41B as a direct target of miR-660-5p via Western blot and dual-luciferase reporter assays.
Conclusions
Our study highlights the upregulation and involvement of miR-660-5p in breast cancer cell proliferation, migration, invasion, and angiogenesis. Additionally, we identified TMEM41B as a direct target of miR-660-5p in breast cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México.
- Facultad de Ciencias Biológicas, Departamento de Biología Celular y Genética, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México. vianey.gonzalezvl@uanl.edu.mx.
- Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico. pablo.vivas@upr.edu.
- Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico. pablo.vivas@upr.edu.
- Department of Biochemistry, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
- Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences (NIGMS) Support for Research Excellence (SuRE) Program (R16)
- Fondo Sectorial de Investigación para la Educación CB2017-2018, Programa Presupuestario F003 of the Consejo Nacional de Humanidades, Ciencia y Tecnología (CONA…
- Consejo Nacional de Humanidades, Ciencia y Tecnología (CONAHCYT) scolarship
Zitieren
APA
Villarreal-García, V., Estupiñan-Jiménez, J. R., Gonzalez-Villasana, V., Vivas-Mejía, P. E., Flores-Colón, M., Ancira-Moreno, I. E., Zapata-Morín, P. A., Altamirano-Torres, C., Vázquez-Guillen, J. M., Rodríguez-Padilla, C., Bayraktar, R., Rashed, M. H., Ivan, C., Lopez-Berestein, G., & Reséndez-Pérez, D. (2024). Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. https://doi.org/10.1186/s41065-024-00357-5
Vancouver
Villarreal-García V, Estupiñan-Jiménez JR, Gonzalez-Villasana V, Vivas-Mejía PE, Flores-Colón M, Ancira-Moreno IE, et al. Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024. doi:10.1186/s41065-024-00357-5
BibTeX
@article{VillarrealGarca2024,
author = {Villarreal-García, Valeria and Estupiñan-Jiménez, José Roberto and Gonzalez-Villasana, Vianey and Vivas-Mejía, Pablo E and Flores-Colón, Marienid and Ancira-Moreno, Irma Estefanía and Zapata-Morín, Patricio Adrián and Altamirano-Torres, Claudia and Vázquez-Guillen, José Manuel and Rodríguez-Padilla, Cristina and Bayraktar, Recep and Rashed, Mohamed H and Ivan, Cristina and Lopez-Berestein, Gabriel and Reséndez-Pérez, Diana},
title = {Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B},
journal = {Hereditas},
year = {2024},
doi = {10.1186/s41065-024-00357-5}
}
EUVIMED